Skip to main content
    H

    Hims Hers Health Inc (HIMS)

    Official site

    HEALTHCARE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE

    $27.72
    -1.99 (-6.70%)

    Market Cap: $6.47B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    57%(13/23)
    Avg Surprise
    -14.25%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.06
    Range$-0.05 - $0.20
    11 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$0.06-6.2%
    60d ago$0.07-13.4%
    30d ago$0.06-6.8%
    7d ago$0.060.0%
    Current$0.06
    Revenue Consensus
    $893M
    Range$884M - $902M
    13 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.60
    Range$-0.95 - $-0.05
    11 analysts
    Revenue Consensus
    $968M
    Range$912M - $1.1B
    14 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.60---
    Sep 26EST
    		-$0.06---
    Jun 26
    Reported Aug 10
    		$-0.10$-0.07-42.86%Miss-134.5%
    Mar 26
    Reported May 11
    		$-0.19$0.13-246.15%Miss-167.9%
    Dec 25
    Reported Feb 23
    		$0.22$0.19+15.79%Beat+100.0%
    Sep 25
    Reported Nov 3
    		$0.28$0.23+21.74%Beat-34.9%
    Jun 25
    Reported Aug 4
    		$0.29$0.23+26.09%Beat+81.2%
    Mar 25
    Reported May 5
    		$0.28$0.23+21.74%Beat+180.0%
    Dec 24
    Reported Feb 24
    		$0.11$0.22-49.43%Miss+1000.0%
    Sep 24
    Reported Nov 4
    		$0.43$0.15+186.67%Beat+616.7%
    Jun 24
    Reported Aug 5
    		$0.16$0.13+23.08%Beat+220.0%
    Mar 24
    Reported May 6
    		$0.10$0.08+25.00%Beat+233.3%
    Dec 23
    Reported Feb 26
    		$0.01$-0.02+150.00%Beat+120.0%
    Sep 23
    Reported Nov 6
    		$0.06$0.05+20.00%Beat+166.7%
    Jun 23
    Reported Aug 7
    		$0.05$0.03+66.67%Beat+150.0%
    Mar 23
    Reported May 8
    		$0.03$0.02+50.00%Beat+137.5%
    Dec 22
    Reported Feb 27
    		$-0.05$-0.07+28.57%Beat+66.7%
    Sep 22
    Reported Nov 7
    		$-0.09$-0.06-50.00%Miss+10.0%
    Jun 22
    Reported Aug 8
    		$-0.10$-0.06-66.67%Miss-11.1%
    Mar 22
    Reported May 9
    		$-0.08$-0.06-33.33%Miss+71.4%
    Dec 21
    Reported Feb 22
    		$-0.15$-0.07-114.29%Miss-114.3%
    Sep 21
    Reported Nov 10
    		$-0.10$-0.06-66.67%Miss-75.1%
    Jun 21
    Reported Aug 11
    		$-0.09$-0.06-50.00%Miss-22.1%
    Mar 21
    Reported May 17
    		$-0.28$-0.07-300.00%Miss-660.0%
    Dec 20
    Reported Mar 18
    		$-0.07N/A+56.25%Beat-333.3%
    Sep 20
    Reported Nov 12
    		$-0.06N/AN/ABeat-385.5%
    Jun 20
    Reported Aug 13
    		$-0.07N/AN/ABeat+69.6%
    Mar 20
    Reported May 13
    		$0.05N/AN/ABeat+118.6%
    Dec 19
    Reported Mar 27
    		$0.03N/AN/ABeat+111.2%
    Sep 19
    Reported Nov 12
    		$0.02N/AN/ABeat-
    Jun 19
    Reported Aug 29
    		$-0.24$0.00N/AMiss-
    Mar 19
    Reported Jun 30
    		$-0.27$0.00N/AMiss-
    Dec 18
    Reported Mar 31
    		$-0.27$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio132.00EV/EBITDAN/A
    Price/FCF104.23xFCF Yield0.96%
    Profitability
    Profit Margin-5.51%Operating Margin-12.80%
    ROE-32.00%ROIC-8.40%
    Financial Health
    Debt/Equity4.21xInterest CoverageN/A
    Current Ratio0.93xQuick Ratio0.87x
    Trading Statistics
    Beta2.43Avg Volume10.17M
    52-Week High$57.4552-Week Low$13.74

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$29.40
    SMA 20$29.20
    SMA 50$29.40
    SMA 200$27.32
    EMA 10$29.29
    EMA 20$29.24
    EMA 50$29.42
    EMA 200$30.44

    MACD

    Line: 0.03Signal: 0.03Hist: -0.00

    ADX

    ADX: 13.1+DI: 19.7-DI: 23.1

    Aroon & PSAR

    Aroon Up36.0
    Aroon Down8.0
    PSAR$31.79

    Bollinger Bands

    Upper Band$31.01
    Lower Band$27.40
    %B Position1235%(Upper)
    Band Width0.09

    RSI (14-Day)

    Neutral
    43.8

    Momentum Oscillators

    Stoch %K44.4
    Stoch %D57.0
    Williams %R-94.7
    ROC (10d)-6.9%
    Momentum-2.07
    CCI (20d)-114.0
    MFI (14d)60.0

    Volatility Measures

    ATR (14d)$1.79(6.5%)
    StdDev (20d)0.90
    Hist Vol63.6%(High)

    Volume Flow

    VWAP$28.32
    OBV233.6M
    AD Line-324.4M
    CMF (20d)-0.105

    Volume Metrics

    Avg Vol (20d)10.4M
    Vol Ratio1.1x
    VWMA (20d)$29.27

    Pivot Points

    R3$32.14
    R2$31.26
    R1$30.49
    Pivot Point$29.61
    S1$28.83
    S2$27.95
    S3$27.17

    Advanced Oscillators

    TSI0.60
    Ultimate Osc45.8
    KST15.60

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$753.21M$608.10M$617.82M$598.98M$544.83M$586.01M$481.14M$401.56M$315.65M$278.17M$246.62M$226.70M
    Cost of Revenue$272.41M$211.32M$173.38M$156.92M$128.64M$155.32M$111.60M$83.67M$59.03M$49.08M$42.56M$39.39M
    Gross Profit$480.80M$396.79M$444.44M$442.06M$416.20M$430.69M$369.54M$317.89M$256.61M$229.09M$204.06M$187.31M
    Operating Expenses$578.00M$475.11M$435.25M$430.25M$389.47M$372.79M$350.94M$295.51M$245.58M$219.19M$204.46M$195.86M
    R&D$54.90M$46.94M$40.96M$40.58M$37.85M$29.91M$23.75M$21.09M$18.65M$15.32M$13.40M$12.27M
    SG&A$165.38M$109.67M$76.17M$80.68M$67.27M$48.61M$48.03M$44.62M$40.55M$34.57M$32.32M$35.91M
    Operating Income$-97,192,000$-78,323,000$9.19M$11.81M$26.72M$57.90M$18.60M$22.37M$11.03M$9.90M$-400,000$-8,554,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$23.23M$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-92,633,000$-101,551,000$18.35M$12.22M$32.85M$60.49M$22.29M$23.59M$13.42M$12.40M$2.20M$-6,916,000
    Income Tax Expense$-6,343,000$-9,436,000$-2,248,000$-3,551,000$-9,652,000$11.01M$-3,734,000$-51,995,000$127,000$1.27M$951,000$651,000
    Net Income$-86,290,000$-92,115,000$20.60M$15.77M$42.51M$49.48M$26.02M$75.59M$13.30M$11.13M$1.25M$-7,567,000
    EBITDA$-61,119,000$-78,139,000$37.47M$31.38M$44.00M$68.08M$27.44M$26.82M$15.86M$14.33M$3.20M$-6,070,000
    EBIT$-92,455,000$-101,551,000$18.35M$12.22M$32.85M$60.49M$22.29M$23.59M$13.42M$12.40M$2.20M$-6,916,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about HIMS

    News

    Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

    Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS) and its officers...

    GlobeNewswire•10/15/26•Bearish

    Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

    Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS) and its officers. The lawsuit alleges that Hims made false and misleading statements...

    The Killeen Daily Herald•10/15/26•Bearish

    Hims & Hers chief legal officer sells $100,576 in stock

    Soleil Boughton, Chief Legal Officer at Hims & Hers Health, Inc. (NASDAQ:HIMS), sold 3,461 shares of company stock for $100,576 on October 14, 2026...

    Investing.com•10/15/26•Somewhat-Bearish

    Bragar Eagel & Squire, P.C. Reminds Hims & Hers Health, Inc. Investors of the Upcoming Lead Plaintiff Deadline and Urges Investors to Contact the Firm

    Bragar Eagel & Squire, P.C. has filed a class action lawsuit against Hims & Hers Health, Inc. on behalf of investors who purchased Hims securities between August 4, 2025, and July 29...

    GlobeNewswire•10/15/26•Bearish

    Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS

    ClaimsFiler is reminding Hims & Hers Health investors with losses over $100,000 that the lead plaintiff deadline for a class action lawsuit against the company is November 2...

    GlobeNewswire•10/15/26•Bearish

    HIMS Valuation and Fair Value

    P/E
    132.0x
    Forward P/E
    73.5x
    P/FCF
    104.2x
    PEG
    2.6x
    P/B
    19.8x
    See GNG's fair value

    HIMS Profitability: Margins, ROIC and FCF

    Gross margin
    68.4%
    Operating margin
    -12.8%
    Net margin
    -5.5%
    ROIC
    -8.4%
    ROE
    -32.0%
    FCF margin
    2.4%
    FCF yield
    1.0%

    HIMS Competitors

    CompanyTicker
    Conagra Brands, Inc.CAG
    ELF Beauty IncELF
    BBB Foods Inc.TBBB
    Albertsons CompaniesACI
    Primo Brands CorporationPRMB
    Ingredion IncorporatedINGR
    Celsius Holdings IncCELH
    Sprouts Farmers Market LLCSFM

    Sector: Consumer Defensive

    HIMS Analyst Ratings

    Consensus
    Hold
    Analysts
    15
    Strong Buy
    2
    Buy
    1
    Hold
    11
    Sell
    0
    Strong Sell
    1

    HIMS Bull Case vs Bear Case

    Bull case

    • HIMS grew quarterly revenue 38.2% year over year.

    Bear case

    • HIMS trades at 132.0x trailing earnings.
    • HIMS has a -5.5% net profit margin.
    • HIMS has a debt-to-equity ratio of 4.2x.

    HIMS Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    -8.3%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.06
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 2 down

    Frequently Asked Questions About HIMS

    Does HIMS pay dividends?

    Hims Hers Health Inc (HIMS) does not currently pay a regular dividend.

    What is HIMS's P/E ratio?

    Hims Hers Health Inc has a price-to-earnings (P/E) ratio of 132.00.

    What is HIMS's market cap?

    Hims Hers Health Inc (HIMS) has a market capitalization of $6.47B with a current stock price of $27.72.

    Related stocks

    Sector: Consumer Defensive

    All stocks starting with H

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In